Since Staphylococcus aureus expresses multiple pathogenic factors, studying their individual roles in singlegene-knockout mutants is difficult. To circumvent this problem, S. aureus clumping factor A (clfA) and fibronectin-binding protein A (fnbA) genes were constitutively expressed in poorly pathogenic Lactococcus lactis using the recently described pOri23 vector. The recombinant organisms were tested in vitro for their adherence to immobilized fibrinogen and fibronectin and in vivo for their ability to infect rats with catheter-induced aortic vegetations. In vitro, both clfA and fnbA increased the adherence of lactococci to their specific ligands to a similar extent as the S. aureus gene donor. In vivo, the minimum inoculum size producing endocarditis in >80% of the rats (80% infective dose [ID 80 ]) with the parent lactococcus was >10 7 CFU. In contrast, clfA-expressing and fnbA-expressing lactococci required only 10 5 CFU to infect the majority of the animals (P < 0.00005). This was comparable to the infectivities of classical endocarditis pathogens such as S. aureus and streptococci (ID 80 ؍ 10 4 to 10 5 CFU) in this model. The results confirmed the role of clfA in endovascular infection, but with a much higher degree of confidence than with single-gene-inactivated staphylococci. Moreover, they identified fnbA as a critical virulence factor of equivalent importance. This was in contrast to previous studies that produced controversial results regarding this very determinant. Taken together, the present observations suggest that if antiadhesin therapy were to be developed, at least both of the clfA and fnbA products should be blocked for the therapy to be effective.Staphylococcus aureus is a major pathogen responsible for a wide variety of infections. These range from relatively mild skin and soft-tissue diseases to severe conditions such as osteomyelitis and endocarditis (35,52). S. aureus also often infects foreign materials (11,19,48,49), thus making it a primary challenge for modern medicine. Finally, S. aureus has successfully collected numerous antibiotic resistance genes and can withstand treatment with the majority of nonexperimental antibacterial drugs, including now glycopeptides (20,40,45). This increases the spectrum of untreatable infections and warrants the search for alternative antistaphylococcal strategies.Understanding the steps of colonization and invasion of the host by the microorganism might greatly help define new targets to interfere with the infective process. However, identifying the key molecular players mediating S. aureus colonization and invasion has been hampered by the multiplicity of pathogenic factors expressed by the organisms. Indeed, S. aureus carries several functionally redundant adhesins binding to both soluble and insoluble components of the host extracellular matrix (39,53). Moreover, the analysis is complicated by the fact that expression of these determinants is differentially regulated by global regulators agr and sar (3, 38), which promote adhesin expression ea...